New and Emerging Targeted Topical and Systemic Drugs for Immunemediated Cutaneous Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 6072
Special Issue Editor
2. Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal
Interests: psoriasis; atopic dermatitis; immunemediated diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Immune-mediated cutaneous diseases are a group of disorders that arise due to abnormal immune system functioning, affecting a significant number of individuals worldwide. These diseases can significantly impact patients' quality of life and cause physical and emotional distress. The pathogenesis of conditions such as psoriasis, atopic dermatitis, alopecia areata, vitiligo, hidradenitis suppurativa, prurigo nodularis, and others involve complex interactions between genetic susceptibility, environmental triggers, and immune system dysregulation.
The understanding of the mechanisms behind these diseases has led to the development of targeted topical and systemic therapies, including biologic agents and small molecules. These therapies work by targeting specific cytokines and signaling pathways involved in disease pathogenesis.
This Special Issue aims to review new and emerging therapies for immune-mediated cutaneous diseases, including psoriasis, atopic dermatitis, alopecia areata, vitiligo, and hidradenitis suppurativa. Articles focused on the latest advances in targeted therapies, as well as promising therapies in development, including novel small molecules and biologic agents, are welcome. Our goal is to provide clinicians and researchers with a comprehensive understanding of the current state of the art in the treatment of these conditions.
Prof. Dr. Tiago Torres
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- psoriasis
- atopic dermatitis
- alopecia areata
- vitiligo
- hidradenitis supurativa
- prurigo nodularis
- urticaria
- cutaneous lupus
- drug targeting
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.